Introduction 35
Extensive studying of nanoparticles during the last decades has resulted in drug delivery systems that protect the active substance, improve solubility and carry the drug to specific tissues in the body (Farokhzad and Langer, 2009 ). Cancer therapy is one of the areas that benefit considerably from these advances (Hirsjärvi et al., 2011) . In order to develop an efficient nanoparticulate drug 40 delivery system, its pharmacokinetic profile as well as biodistribution should be evaluated when the system is transferred from in vitro assays to first preclinical tests. Molecular imaging offers tools for non-invasive evaluation (Baker, 2010) , and the same probes used also allow tissue distribution determination after animal sacrifice. Commonly used small animal imaging technologies include Xray computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography 45 (PET), single photon emission computed tomography (SPECT) and different optical imaging techniques . Optical imaging techniques are sensitive, non-ionizing, fast and easy to perform, portative and cheap. However, quantitative performance of optical techniques still needs improvement in order to overcome the problems of absorption and autofluorescence. SPECT can overcome optical imaging problems because it provides more reliable quantitative information 50 about physiological functions at the molecular level and it is, thus, well suited for monitoring many vital processes such as blood flow and perfusion, receptor-ligand binding rates, and oxygen utilization. SPECT has no depth limit but the acquisition times might be from several minutes up to hours. However, SPECT suffers from some noteworthy other disadvantages such as the need of radiolabelled particles, and adapted and expensive devices. Both SPECT and optical imaging 55 possess a resolution of 1 mm (for more detail, please see ).
Biocompatible nanoparticles for drug delivery are usually made of polymer or lipid materials (Kumari et al., 2010; Müller et al., 2011; Torchilin, 2007; Torchilin, 2005) . Lipid nanocapsules inserm-00855672, version 1 -29 Aug 2013 (LNC) are synthetic particles having a hybrid structure between polymer nanoparticles and 60 liposomes (Heurtault et al., 2002) . LNC consist of low-toxicity materials (PEGylated surfactant, lecithin, triglycerides) and their fabrication, based on low-energy organic solvent-free phase inversion process, can be easily scaled up. By changing proportions of the components, the LNC size can be tuned within the range of 20-100 nm (Heurtault et al., 2003) . LNC have been applied e.g. in the delivery of cancer therapeutics (Cirpanli et al., 2011; Garcion et al., 2006; Lacoeuille et 65 al., 2007; Paillard et al., 2010; Peltier et al., 2006; Weyland et al., 2011) and other drug molecules (Lamprecht et al., 2004) as well as macromolecules such as siRNA and DNA (Morille et al., 2010; Morille et al., 2011) . Because of their semi-rigid shell, LNC can be modified by post-inserting amphiphilic molecules. This kind of post-insertion allows for e.g. improvement of biodistribution profiles (Hoarau et al., 2004; Morille et al., 2010) or creation of templates for further attachment of 70 active targeting ligands (Béduneau et al., 2008; Béduneau et al., 2007; Bourseau-Guilmain et al., 2012) . Radioactive molecules such as 99m Tc and 188 Re have been successfully encapsulated in LNC as forms of lipophilic complexes (Ballot et al., 2006) . These kinds of radio-labelled LNC can be used in biodistribution studies, imaging purposes and in radiotherapy (Allard et al., 2008; Ballot et al., 2006; Vanpouille-Box et al., 2011a; Vanpouille-Box et al., 2011b) . 75
In a previous study, we have evaluated the biodistribution profile of LNC of three different sizes (25, 50 and 100 nm) with the help of an optical imaging technique, fluorescence reflectance imaging (2D-FRI) (Hirsjärvi et al., 2013) . Nude mice bearing subcutaneous HEK293(β 3 ) (human embryonic kidney) xenografts were used in the study. Images taken at 1.5-3 h after intravenous 80 injection revealed that fluorescence staining of the smallest LNC (25 nm) was more homogeneous throughout the mice than the staining of the bigger LNC: the 50 and 100 nm LNC were found mostly in the liver. However, when the mice were sacrificed after 24 h, tissue distribution profiles, Tc-SSS complex. The complex was extracted with dichloromethane (1 mL) and washed three times with 1 mL water.
LNC preparation and characterization

125
LNC were prepared by the phase inversion temperature method described by Heurtault et al. (Heurtault et al., 2003) . Solutol®, Lipoid®, Labrafac®, NaCl and water were mixed and the stirring. The formulation was heated to 85 °C at a rate of 5 °C / min followed by cooling at the same rate to 65 °C. This cycle was repeated twice. During the last decrease of temperature, at 78 °C (during the phase inversion zone), the system was diluted with 4.2 mL cold (4 °C) water leading to inserm-00855672, version 1 -29 Aug 2013 formation of stable LNC. Size of the LNC (25, 50, 100 nm) was adjusted by changing the proportions of the components (Table 1) . 135
Size distributions and zeta (ζ) potentials of LNC were determined with a Zetasizer ZS (Malvern, Worcestershire, UK). Particle sizing was based on photon correlation spectroscopy (PCS); the results were analyzed by CONTIN algorithm and the sizes were presented based on the volume distributions together with polydispersity indices (PdI). Electrophoretic mobilities were converted 140 to ζ-potentials using Smoluchowski's equation.
Cells
HEK293(β 3 ) cells, stable transfectants of human β 3 from the human embryonic kidney cell line 145 (kindly provided by J.-F. Gourvest, Aventis, France), were cultured in DMEM supplemented with 1% glutamine, 10% fetal bovine serum (FBS), 50 units/mL penicillin, 50 µg/mL streptomycin, and 700 µg/mL Geneticin (G418 sulfate, Gibco, Paisley, UK), at 37 °C in a humidified 95% air / 5% CO 2 atmosphere. 150
In vivo imaging and biodistribution study
The animal experiments were performed in agreement with the EU Directive 2010/63/EU for animal experiments, and the "Principles of Laboratory Animal Care" (NIH Publication no. 86-23, revised 1985) , and the experimental protocol was approved by the local ethics committee. In γ-scintigraphy, the injected mice were visualized under a clinical γ-camera (Sopha Medical 165 DSXi, 140 keV±15%, 128 2 matrix, HRLE collimator). Static 15 min scintigraphic images were registered at 1.5 h, 3 h, 5h, and 24 h (a video clip of dynamic 30 s scintigraphic acquisitions collected until 90 min post-injection is available as Supporting Content). To study tissue distribution of LNC, the animals were sacrificed at 1.5 h (n = 4), 4 h (n = 4), and 24 h (n = 4) after injection. The organs/tissues were removed, rinsed, and weighed. Activity of each removed organ 170 was determined using a γ-counter (Packard Auto-Gamma 5,000 series). 
Statistical analysis
185
Biodistribution data was analyzed using one-way ANOVA with Tukey's multiple comparison test (Prism, GraphPad Software, Inc., La Jolla, CA). p < 0.05 was considered as statistically significant.
Results
190
LNC preparation
Size and ζ-potential of 99m Tc-LNC are presented in Table 2 . These characteristics of DiD-LNCs were identical with 99m
Tc-LNC (Hirsjärvi et al., 2013) . PdI-values of all three types of LNC were low indicating homogeneous size distributions. Slightly negative ζ-potential of LNC originates from 195 PEG groups at the surface forming dipoles able to interact with counterions or water dipoles (Vonarbourg et al., 2005) . Encapsulation of lipophilic 99m Tc or DiD in the oily core of LNC did change neither size nor ζ-potential of the blank LNC as reported earlier (Ballot et al., 2006; Morille et al., 2010; Paillard et al., 2010; Zou et al., 2008) . injections are presented in Figure 1 . LNC 25 nm disappeared quickly from the blood circulation: 3-6% total CPM (counts per minute) / g of the 25 nm LNC was found in the blood at 1.5-4 h whereas 205 the measured blood activities for LNC 50/100 nm were about 25-30 % at the same time points (p < 0.001: LNC 25 nm vs. LNC 50/100 nm). Conversely, at 24 h, total CPM / g of LNC 25 nm was higher (~3%) than the corresponding LNC 50/100 nm values (~1.5%; p < 0.01). More activity of inserm-00855672, version 1 -29 Aug 2013 LNC 25 nm was found in the liver at 1.5-4 h (~28%) compared to LNC 50 nm (16-18%; p < 0.01) and LNC 100 nm (21-22%; difference not significant). Also, compared to LNC 50/100 nm, more 210 LNC 25 nm were found in the heart and in the lung (p < 0.01), and in the adrenal at 1.5-4 h. In contrast, at 24 h, less LNC 50 nm was found in the heart, lung and kidney compared to LNC 25/100 nm (p < 0.05). The spleen captured less LNC 50 nm than LNC 25/100 nm at 1.5 h and 4 h (p < 0.05). No significant differences were found in the tumour accumulation between the three particle sizes at different time points (1-3% total CPM / g). Otherwise, distribution in other organs was 215 similar at different time points.
γ-Scintigraphic images of mice 1.5 h, 3 h, 5 h, and 24 h after i.v. injection of 25, 50 and 100 nm 99m Tc-LNC are presented in Figure 2 . The livers were well visible at 24 h. At earlier time points, especially at 1.5 h and 3 h, more vertical highlighted regions revealed also radioactivity in the blood 220 circulation (heart, lungs). LNC 25 nm were better observable than LNC 50/100 nm in peripheral regions and at intestinal area of mice at 3 h and 5 h. These observations were supported by the γ-counting results: if the values "% CPM of all organs" were not corrected by the organ masses, radioactivity in the carcass after the injection of LNC 25 nm were 39% at 1.5 h and 37% at 4 h.
Corresponding values for LNC 50 and 100 nm were 22% (p < 0.001 vs. LNC 25 nm) and 22% (p < 225 0.001); 15% (p < 0.01) and 18% (p < 0.05) at 1.5 h and 4 h, respectively. Also, at 4 h, 7.5% of LNC 25 nm were found in the intestine vs. 4.5% of LNC 50 nm and 3% of LNC 100 nm (both p < 0.01
vs. LNC 25 nm).
Comparison of in vivo biodistribution of co-injected 99m
Tc-LNC and DiD-LNC 230
An example of fluorescence images of a mouse 24 h after injection of a 50%-50% mixture of 50 nm
DiD-LNC and 99m
Tc-LNC is presented in Figure 3 . Fluorescence staining allowed identifying of the inserm-00855672, version 1 -29 Aug 2013 liver (A) and the tumour (B). LNC biodistribution in different organs at 24 h is presented in Figure   4 . To better compare the quantification by the two techniques (γ-counting and fluorescence 235 imaging), the organ data were normalized by the detected radioactivity (% ID/g) and fluorescence intensity (RLU/pixel/20 ms) in the bone. As already observed when testing radiolabelled LNC of different sizes, the majority of radioactivity was found in the liver as well as in the adrenal, spleen, and kidneys (Fig. 4A) . Instead, the observed fluorescence intensity was also highest in the liver, but the next highest fluorescent organs were the ovaries, adrenal, and skin. The global fluorescence 240 intensity in the spleen was low, and moderate in the kidneys. Radioactivity in relation to other organs was clearly higher in the liver, adrenal, spleen, kidney, ovary, and lung. No such clear differences were observed in fluorescence intensities. An image of the organs (Fig. 4B) , used for the quantification, reveals well the highly fluorescent organs.
245
Discussion
Generally, sub-100 nm nanoparticles are expected to circulate longer time in the blood compared to > 100 nm particles (Vonarbourg et al., 2006) . However, in the size range of 10-100 nm, surface and even elasticity properties of nanoparticles as well as their mechanism of elimination have been 250
shown to dictate pharmacokinetic and biodistribution profiles. Also, animal model (mouse/rat) is known to affect tissue distribution (Sun et al., 2005) . For example, systemic clearance and volume of distribution of 60 nm PEGylated polyacrylate nanoparticles in mice were significantly lower when compared to 20 nm particles, leading to lower liver uptake (~15% ID/g at 48 h) of the larger 60 nm particles (Yang et al., 2009) . Similarly, 25 nm polymer micelles exhibited much shorter 255 circulation half-lives than 60 nm micelles (2.2-fold decrease in the distribution phase t 1/2 ) . More efficient clearance by hepatobiliary excretion of the smaller micelles was proposed as ~70% of the (mouse) liver fenestrations are narrower than 100 nm. The longest blood half-life of inserm-00855672, version 1 -29 Aug 2013 10-100 nm PEGylated gold nanoparticles was achieved with ~60 nm particles by adjusting the size and PEG length (Perrault et al., 2009 ). On the other hand, mice plasma clearance rates (12% ID/mL 260 plasma at 24 h), and the quantities in kidney (~4% ID/g), liver (10-16% ID/g) and in spleen (5-10% ID/g) were similar regardless of the polymer micelle size (30-100 nm) (Cabral et al., 2011) . Several studies have proposed wider distribution, extravasation, of nanoparticles in different organs, the smaller the particle size was in the sub-100 nm range (De Jong et al., 2008; Hirn et al., 2011; Sonavane et al., 2008; Yang et al., 2009) . Similarly to our results with 25, 50, and 100 nm LNC, 265 shortened blood circulation time is frequently related to this wider biodistribution. Higher quantity of LNC 25 nm in the liver (1.5, 4 h) compared to LNC 50/100 nm in the current study indicated also faster hepatic accumulation. Radioactivity found in the kidneys can be explained by LNC accumulation. To undergo a complete renal clearance, the nanoparticle size should be less than 10 nm (Choi et al., 2007) . Instead, 75±25 nm PEGylated gold nanoparticles are reported to enter the 270 fenestrated glomerular endothelia (80-100 nm pores) and accumulate in the kidney mesangium (Choi et al., 2011) . Nanoparticle accumulation in the ovaries, clearly visible in the case of LNC (Fig. 4) , is assumed to originate from fast growing and, thus, highly vascularized nature of the ovarian corpus luteum of mature female mice that leads to the EPR (enhanced permeability and retention) effect, described initially for tumours (Schädlich et al., 2012) . 275
In our previous study, after i.v. injection, signals of fluorescent-labelled LNC 25 nm in the skin and in the intestine were found to be more intense than the corresponding signals of LNC 50/100 nm (Hirsjärvi et al., 2013) . Thus, the results of the current study confirmed these findings. Almost twice the radioactivity of LNC 25 nm in carcass compared to LNC 50/100 nm at 1.5-4 h indicated, 280
indeed, that the smallest LNC were distributed rapidly to the peripheral capillaries and probably perfused further to tissues increasing the skin fluorescence. Higher LNC 25 nm quantities in the intestine suggested more pronounced hepato-biliary evacuation. Differences in the elimination rate inserm-00855672, version 1 -29 Aug 2013 of the three LNC could not be, however, revealed when estimated injected doses were compared to CPM of all organs. For each LNC type, differences between the different time points remained 285 within 10% and were not significantly different.
Magnitude of the tumour accumulation of nanoparticles by the EPR effect together with a therapeutic effect (of an encapsulated drug) remains in general in the range of 3.5-12% (ID/g) (de Wolf et al., 2007; Kircheis et al., 2002; Kursa et al., 2002; Meng et al., 2011) . Accumulation of 290 LNC 25-100 nm in HEK293(β 3 ) tumour was a bit lower (1-3%). It should be noted, however, that this subcutaneous model is an "EPR-weak" tumour having well-structured, neo-angiogenic vasculature with tight endothelial junctions (Jin et al., 2007; Razkin et al., 2006) . γ-Imaging of dual-labelled (radio+fluorescence) PEGylated polyacrylate nanoparticles revealed 295 radioactivity in the cardiac area at early observation time points (5 min -4 h) followed by increasing activity in liver and spleen up to 48 h (Yang et al., 2009) . Tumour was poorly observable by γ-imaging but, instead, optical imaging that enhanced subcutaneous signal compared to deep signals, showed clear fluorescence staining in tumour. Subcutaneous tumours were well visualized by strongly surface-weighted optical imaging. Therefore, as in our studies ( (Hirsjärvi et al., 2013 ) 300 and the current study), optical imaging offers better resolution imaging especially for superficial organs whereas γ-scintigraphy recapitulates the global biodistribution of radiolabelled compounds in both internal and superficial organs.
To better compare the biodistribution of LNC measured by the two techniques, radioactivity and 305 fluorescence intensity, the corresponding results were normalized by the value observed in the bone. The bone was selected because its radioactivity / fluorescence intensity level was observed to be settled in the middle of all analysed organs, allowing, thus, distinct representation of the data. In
inserm-00855672, version 1 -29 Aug 2013
order to quantify fluorescence intensity of dissected organs, graphical ROI estimation from images visualized by a fluorescent camera is commonly performed. (Goutayer et al., 2010; Kim et al., 310 2010; Na et al., 2011; Sancey et al., 2009; Schädlich et al., 2011a; Schädlich et al., 2011b; Yang et al., 2007) . Alternatively, homogenization of each dissected organ followed by determination of the fluorescence intensity on a microtiter plate can be done (He et al., 2010; Meng et al., 2011) . The fluorescence intensity technique (ROI drawing and estimation), compared to γ-counting, underestimated the LNC proportion in all the red and the dark red organs such as RES organs (liver, 315 lung, spleen), and the kidney and adrenal. These organs are characterized by high blood perfusion.
Similarly to our findings, ex vivo quantification of fluorescence intensity underestimated the uptake of polymer micelles in the liver, spleen, kidney, and also in the heart (Yang et al., 2007) . For this reason, relative fluorescence intensity in other organs was found to be emphasized. Because of the fluorescence quantification technique in this study, intensities of thin organs (i.e. skin) were also 320 slightly highlighted. It should be noted that direct comparison of the two quantification techniques after normalization (Fig. 4) is not recommendable but, instead, this approach revealed well the relative differences between the organs within each technique.
Conclusions 325
Biodistribution studies of radiolabelled h e a r t l u n g s k i n l i v e r s p l e e n p a n c r e a s a d r e n a l k id n e y s t o m a c h i n t e s t i n e 
